Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP3 | P42574 | 4/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.46 |
| ▸ | MDM4 | O15151 | 2/20 | 0.44 |
| ▸ | TP53 | P04637 | 2/20 | 0.44 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.42 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29401144 | 1.00 | CASP3 (0.48) | CASP3KMT2AEPHX2MDM4TP53 | |
| SCHEMBL12798422 | 1.00 | CASP3 (0.48) | CASP3KMT2AEPHX2MDM4TP53 | |
| SCHEMBL7650015 | 1.00 | CASP3 (0.48) | CASP3KMT2AEPHX2MDM4TP53 | |
| SCHEMBL29401786 | 0.88 | CASP3 (0.52) | CASP3KMT2AEPHX2MDM4TP53 | |
| SCHEMBL3070048 | 0.88 | CASP3 (0.52) | CASP3KMT2AEPHX2MDM4TP53 | |
| SCHEMBL30656017 | 0.88 | CASP3 (0.52) | CASP3KMT2AEPHX2MDM4TP53 | |
| SCHEMBL29368798 | 0.88 | CASP3 (0.52) | CASP3KMT2AEPHX2MDM4TP53 | |
| SCHEMBL29692865 | 0.88 | CASP3 (0.47) | CASP3KMT2AEPHX2PIN1 | |
| SCHEMBL5706475 | 0.87 | CASP3 (0.47) | CASP3KMT2AEPHX2MDM4TP53 | |
| SCHEMBL5706460 | 0.86 | PTPN1 (0.48) | CASP3KMT2AMDM4TP53MDM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12265082-B2 | Detecting microbial infection in wounds | SYNOVO GMBH (DE) | 2025-04-01 | — | — | US | disclosed |
| US-20250092088-A1 | PEPTIDE COMPOUND PRODUCTION METHOD | CHUBU UNIVERSITY EDUCATIONAL FOUNDATION (JP) | 2025-03-20 | — | — | US | disclosed |
| EP-4425181-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | Bertis Inc (KR) | 2024-09-04 | — | — | EP | disclosed |
| US-20240027454-A1 | DETECTING MICROBIAL INFECTION IN WOUNDS | SYNOVO GMBH (DE) | 2024-01-25 | — | — | US | disclosed |
| US-20240011979-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTES | BERTIS INC. (KR) | 2024-01-11 | — | — | US | disclosed |
| CN-116829949-A | Compositions for detecting or measuring analytes | 伯蒂斯有限公司 | 2023-09-29 | — | — | CN | disclosed |
| US-11740241-B2 | Construct including an anchor, an enzyme recognition site and an indicator region for detecting microbial infection in wounds | SYNOVO GMBH (DE) | 2023-08-29 | — | — | US | disclosed |
| WO-2023136301-A1 | PEPTIDE COMPOUND PRODUCTION METHOD | 学校法人中部大学 | 2023-07-20 | — | — | WO | disclosed |
| WO-2023075435-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | 주식회사 베르티스 | 2023-05-04 | — | — | WO | disclosed |
| CN-109564213-B | Detecting microbial wound infection | 西诺福有限公司 | 2023-01-31 | — | — | CN | disclosed |
| US-20220283131-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTES | BERTIS CO., LTD. (KR) | 2022-09-08 | — | — | US | disclosed |
| WO-2022050529-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | ㈜베르티스 | 2022-03-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250092088-A1 | PEPTIDE COMPOUND PRODUCTION METHOD | VIP, NPPA, HM13 | CASP3 2652/4885KMT2A 3104/4885EPHX2 2924/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.